• Sun Pharma reported 14.3% quarter-on-quarter (QoQ) growth in its consolidated revenues for the quarter ended June (Q1FY22). On a year-on-year (YoY) basis, it increased by 27.6%.
  • Its expenses for the quarter were up by 5.4% QoQ and 18.2% YoY.
  • While the pharma major’s net profit increased by 61.5% QoQ during the June 2021 quarter, it reported a net profit of Rs 1,444 crores versus a net loss of Rs 1,656 crores in the same quarter last year.
  • The earnings per share (EPS) of Sun Pharma stood at 6 during Q1FY22.

Sun Pharma’s Financial Statements for Q1FY22:

(Rs, crores) Q1FY21 Q4FY21 Q1FY22 QoQ (%) YoY (%)
Total Income 7,739 8,634 9,871 14.3% 27.6%
Total Expenses 6,290 7,058 7,436 5.4% 18.2%
Profit before tax -2,184 903 1,804 99.8% -
Tax 246 55 396 618.7% 60.9%
Profit after tax -1,656 894 1,444 61.5% -
Earnings per share -6.9 3.7 6.0    

Data Source: BSE, Company announcements

Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results